We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ubiquitin Ligase Protects Against Autoimmune Disease

By Biotechdaily staff writers
Posted on 12 Sep 2004
Researchers have found that the ubiquitin ligase Cbl-b plays a critical role in preventing the development of arthritis and other autoimmune diseases.

Ubiquitin (Ub) is a small protein composed of 76 amino acids. More...
This protein is found in all cells of eukaryotic organisms. Ubiquitin is highly conserved, meaning that the amino acid sequence does not differ much when very different organisms are compared. For example, there are only three differences in the sequence when Ub from yeast is compared to human Ub. This strong sequence conservation suggests that the vast majority of amino acids that make up Ub are essential, as apparently any mutations that have occurred over evolutionary history have been removed by natural selection.

Ubiquitin becomes attached covalently to certain residues of other proteins. The attachment of a chain of ubiquitins tags a protein for intracellular proteolytic destruction. Ubiquitin ligases are a class of enzymes that determines the substrate protein to which a ubiquitin will be linked and that binds the ubiquitin to this protein. Many ubiquitin ligases are multi-subunit proteins.

In the current study, investigators from the La Jolla Institute for Allergy and Immunology (San Diego, CA, USA) and the Institute for Molecular Biotechnology of the Austrian Academy of Sciences (Vienna, Austria) worked with mice genetically engineered to lack the gene for Cbl-b. These mice as well as a normal control group were injected with substances known to induce arthritis. Results reported in the August 2004 issue of Immunity revealed that while the normal mice did not respond to the injection, the mice lacking Cbl-b developed severe symptoms of arthritis.
"We concluded that the Cbl-b molecule was affecting the T cell's immune response, giving the immune system of the normal mice the ability to ‘tolerate' the arthritis antigens,” explained contributing author Dr. Yun-Cai Liu, a researcher at the La Jolla Institute for Allergy and Immunology. "The mice without the Cbl-b molecule could not tolerate these substances and their T cells began attacking their own tissues, leading to the development of the autoimmune disease.”

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Aspiration System
VACUSAFE
New
Clinical Informatics Platform
CLARION™
New
Total Laboratory Automation Solution
SATLARS Mini T8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.